The Korea Disease Control and Prevention Agency on Thursday said it would secure some 7.23 million doses of mRNA-based COVID-19 vaccines for winter this year for individuals at a higher risk of developing the illness as variants of the virus continue to pose a risk to public health. Additionally, the government has decided to convert a portion of homegrown COVID-19 vaccines into NovaVax’s synthetic antigen vacc.